X linked agammaglobulinaemia with a 'leaky' phenotype. 1996

A Jones, and L Bradley, and L Alterman, and M Tarlow, and R Thompson, and C Kinnon, and G Morgan
Molecular Immunology Unit, Institute of Child Health, London.

Typical X linked agammaglobulinaemia (XLA) is characterised by absence of immunoglobulin production and lack of mature B cells. The gene responsible for XLA has recently been identified, and codes for a B cell tyrosine kinase, BTK. A family affected by a B cell immunodeficiency, which is less severe than classical XLA, is described but they had a pedigree suggestive of X linked inheritance. Demonstration of a mutation in the BTK gene confirms that this is a mild form of XLA.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008040 Genetic Linkage The co-inheritance of two or more non-allelic GENES due to their being located more or less closely on the same CHROMOSOME. Genetic Linkage Analysis,Linkage, Genetic,Analyses, Genetic Linkage,Analysis, Genetic Linkage,Genetic Linkage Analyses,Linkage Analyses, Genetic,Linkage Analysis, Genetic
D008297 Male Males
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D011505 Protein-Tyrosine Kinases Protein kinases that catalyze the PHOSPHORYLATION of TYROSINE residues in proteins with ATP or other nucleotides as phosphate donors. Tyrosine Protein Kinase,Tyrosine-Specific Protein Kinase,Protein-Tyrosine Kinase,Tyrosine Kinase,Tyrosine Protein Kinases,Tyrosine-Specific Protein Kinases,Tyrosylprotein Kinase,Kinase, Protein-Tyrosine,Kinase, Tyrosine,Kinase, Tyrosine Protein,Kinase, Tyrosine-Specific Protein,Kinase, Tyrosylprotein,Kinases, Protein-Tyrosine,Kinases, Tyrosine Protein,Kinases, Tyrosine-Specific Protein,Protein Kinase, Tyrosine-Specific,Protein Kinases, Tyrosine,Protein Kinases, Tyrosine-Specific,Protein Tyrosine Kinase,Protein Tyrosine Kinases,Tyrosine Specific Protein Kinase,Tyrosine Specific Protein Kinases
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004303 Dosage Compensation, Genetic Genetic mechanisms that allow GENES to be expressed at a similar level irrespective of their GENE DOSAGE. This term is usually used in discussing genes that lie on the SEX CHROMOSOMES. Because the sex chromosomes are only partially homologous, there is a different copy number, i.e., dosage, of these genes in males vs. females. In DROSOPHILA, dosage compensation is accomplished by hypertranscription of genes located on the X CHROMOSOME. In mammals, dosage compensation of X chromosome genes is accomplished by random X CHROMOSOME INACTIVATION of one of the two X chromosomes in the female. Dosage Compensation (Genetics),Gene Dosage Compensation,Hypertranscription, X-Chromosome,X-Chromosome Hypertranscription,Compensation, Dosage (Genetics),Compensation, Gene Dosage,Compensation, Genetic Dosage,Dosage Compensation, Gene,Gene Dosage Compensations,Genetic Dosage Compensation,Genetic Dosage Compensations,Hypertranscription, X Chromosome,X Chromosome Hypertranscription
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000361 Agammaglobulinemia An immunologic deficiency state characterized by an extremely low level of generally all classes of gamma-globulin in the blood. Hypogammaglobulinemia,Agammaglobulinemias,Hypogammaglobulinemias

Related Publications

A Jones, and L Bradley, and L Alterman, and M Tarlow, and R Thompson, and C Kinnon, and G Morgan
June 2005, Clinical and experimental immunology,
A Jones, and L Bradley, and L Alterman, and M Tarlow, and R Thompson, and C Kinnon, and G Morgan
December 1989, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
A Jones, and L Bradley, and L Alterman, and M Tarlow, and R Thompson, and C Kinnon, and G Morgan
May 2000, Clinical and experimental immunology,
A Jones, and L Bradley, and L Alterman, and M Tarlow, and R Thompson, and C Kinnon, and G Morgan
May 1991, Journal of clinical pathology,
A Jones, and L Bradley, and L Alterman, and M Tarlow, and R Thompson, and C Kinnon, and G Morgan
January 2004, Scandinavian journal of rheumatology,
A Jones, and L Bradley, and L Alterman, and M Tarlow, and R Thompson, and C Kinnon, and G Morgan
March 2008, Clinical and experimental dermatology,
A Jones, and L Bradley, and L Alterman, and M Tarlow, and R Thompson, and C Kinnon, and G Morgan
September 2000, European journal of gastroenterology & hepatology,
A Jones, and L Bradley, and L Alterman, and M Tarlow, and R Thompson, and C Kinnon, and G Morgan
October 2007, Journal of clinical pathology,
A Jones, and L Bradley, and L Alterman, and M Tarlow, and R Thompson, and C Kinnon, and G Morgan
January 1981, Acta neuropathologica. Supplementum,
A Jones, and L Bradley, and L Alterman, and M Tarlow, and R Thompson, and C Kinnon, and G Morgan
May 1993, Lancet (London, England),
Copied contents to your clipboard!